Skip to main content
Displaying 960 of 2878 articles.

Sohail Tavazoie promoted to professor

Sohail Tavazoie, a physician-scientist who studies the genes that regulate a tumor’s ability to metastasize, has been promoted to professor.

Rockefeller takes first place in global ranking of scientific impact

Out of over 900 universities from 55 different countries, Rockefeller tops a survey measuring the impact of university research publications, scoring the highest percentage of frequently cited scientific publications.

Small molecule from Kapoor lab is accepted as first Bridge Medicines drug candidate

A chemical inhibitor targeting basal cell carcinoma, originating from Tarun Kapoor’s lab, is graduating from the Tri-Institutional Therapeutics Discovery Institute into Bridge Medicines.

Astrophysicist Kip Thorne to receive Rockefeller’s 2018 science writing prize

Thorne is recognized for his deft explanations that have drawn readers into the space-, time-, and mind-bending realm of Einstein’s ideas. The prize, which honors scientists as inspirational authors, will be presented on April 17.

Günter Blobel, a Nobel laureate who redefined cell biology, has died

Günter Blobel, a Nobel Prize-winning Rockefeller biologist who discovered the mechanisms by which proteins are targeted for delivery to specific locations within cells, died February 18 at 81.

Proof of principle: Tri-I TDI drug candidates “graduate” to next phase of development

As inaugural Sanders Director Dr. Michael Foley is set to depart the Tri-Institutional Therapeutics Discovery Institute later this year, two projects from a portfolio of 57 that the Tri-I TDI has supported are now ready for the next phase of therapeutic development—a phase intended to lead to inv...

Neuroscientist Vanessa Ruta promoted to associate professor

Ruta, who explores how brains produce such flexible responses to fixed stimuli, has been promoted to Gabrielle H. Reem and Herbert J. Kayden associate professor.

Daniel Kronauer, who uses ants to study social behavior, is promoted

Kronauer has been promoted to associate professor. He has dedicated his laboratory to investigating the molecular basis underlying complex social behavior among insects.

Statistical physicist and Rockefeller Professor Emeritus E.G.D. “Eddie” Cohen dies at 94

Cohen was an emeritus faculty member at The Rockefeller University and leader in statistical physics and nonequilibrium statistical mechanics. He died September 24 at the age of 94.

JoAnne Stubbe of MIT will receive the 2017 Pearl Meister Greengard Prize

Stubbe is being recognized for illuminating the processes that drive DNA replication and repair. Her research has led to the development of several cancer therapies.

Rockefeller is a leading institution in Nature Index ranking of innovation

The ranking evaluates how research articles are cited in patents, showing the influence of research on the development of products and services.

23 students receive Ph.D.s at Rockefeller’s 59th convocation

The Rockefeller University today awards doctoral degrees to 23 students who have completed their studies in bioscience. In addition, four distinguished scientists—Anthony B. Evnin, Mary-Claire King, Matthew Meselson, and Steven Weinberg—will receive honorary doctor of science degrees.

Hundreds of children and their families attend Rockefeller’s Science Saturday festival

The fourth annual science festival drew more than 1,000 school-age children and their families to campus. The young explorers participated in hands-on experiments and interactive demonstrations led by scientists.

Reem–Kayden Early-Career Innovation Award is established to support newly promoted associate professors at Rockefeller

The unique award, funded by a $7 million gift, is designed to encourage Rockefeller’s early-career faculty members to pursue the most imaginative science in the years leading to a tenure decision. All heads of laboratories are eligible upon their promotion to associate professor.

Pablo G. Legorreta, founder and chief executive officer of Royalty Pharma, is elected to the Board

Rockefeller’s Board of Trustees elected new member Pablo G. Legorreta, the founder and CEO of Royalty Pharma, at their February 15 meeting. With his election, the university has 49 voting members.

Rockefeller president Richard P. Lifton releases statement on proposed federal budget cuts to science

Rockefeller University President Richard P. Lifton today released the following statement on proposed cuts to federal funding for science: Given the remarkable track record of American science, one can only read with alarm the White House budget proposal recommending an 18 percent reduction in NI...

Marc Tessier-Lavigne and Mary Hynes donate Ursula von Rydingsvard sculpture to university’s art collection

The former Rockefeller president and his wife made the gift to express their thanks to the university community. The dramatic cedar sculpture, called Plate with Dots, was installed earlier this month in the Abby Lounge.

Rockefeller’s redesigned website set to launch in March

It has been more than a decade since Rockefeller’s most prominent public face received a major overhaul. That’s set to change next month, when the initial phase of a reimagined and redesigned rockefeller.edu launches. The new external site, which has taken two years to carefully plan and rebuild...

Talking Science lecture introduces students to the genetic aspects of infectious diseases

As he opened this year’s Talking Science lecture, geneticist Jean-Laurent Casanova made a stark observation to his teenage audience: “If we had been here 150 years ago, about half of you would already have died.” The primary reason, he told the 350 high school students and 60 teachers present,...

Carolyn Walch Slayman, Rockefeller alumna and pioneer woman in science, dies at 79

Carolyn Walch Slayman, who was one of the first women to graduate from Rockefeller’s Ph.D. program, died last December at the age of 79. Dr. Slayman spent nearly 50 years at the Yale School of Medicine, where she was Sterling Professor of Genetics and deputy dean for academic and scientific affai...

Newly discovered beetle species named after Rockefeller’s Daniel Kronauer

 Scientists can rack up many awards, but to have one’s name cemented in scientific nomenclature is a special kind of honor. In an homage to his mentor Daniel Kronauer, former Rockefeller postdoctoral associate Christoph von Beeren has named a new species of beetle Nymphister kronaueri. ...

Rockefeller president Richard P. Lifton releases statement on U.S. immigration policy

In response to an executive order on immigration issued by President Donald J. Trump Friday, Rockefeller University President Richard P. Lifton today released the following statement: We at Rockefeller University, a world-renowned center for research in the biomedical sciences, oppose both the sp...

Pels Family Center for Biochemistry and Structural Biology receives new $10 million grant

by Alexandra MacWade, assistant editor A new $10 million endowment gift made by the Donald A. Pels Charitable Trust will provide ongoing support for the university’s chemical and structural biologists through the Pels Family Center for Biochemistry and Structural Biology. Mr. Pels, who was a Roc...

Rockefeller’s annual Celebrating Science benefit raises $2.8 million, an all-time record

by Alexandra MacWade, assistant editor Last month, 400 guests gathered on campus for cocktails, a lecture on next-generation genomics given by Robert B. Darnell, and a festive dinner. The event—Rockefeller’s fifth annual Celebrating Science benefit—raised a record $2.8 million for the uni...

Molecular biologist Bonnie Bassler receives Rockefeller’s Pearl Meister Greengard Prize

by Alexandra MacWade, assistant editor For hundreds of years, bacteria were thought of as reclusive, antisocial organisms. But molecular biologist Bonnie Bassler, known to some as the “Bacteria Whisperer,” discovered that these single-celled creatures actually talk to one another and c...

Neuroscientist Huda Y. Zoghbi is elected to the Board

by Alexandra MacWade, assistant editor Huda Y. Zoghbi, a pediatric neurologist and neuroscientist who has made key discoveries in the study of brain disorders, has been elected to Rockefeller’s Board of Trustees. With her election, which took place at the Board’s October 19 meeting, the univ...

Rockefeller’s Science Outreach program explores the microbes in food

If you’ve ever forgotten about a cheese wedge in the fridge, you may have discovered something mysterious growing on it, a sure sign that it’s no longer edible. But have you ever wondered where the microbes responsible for that change came from? That’s one of several questions that the late...

Gaby Maimon, who studies sophisticated brain functions in fruit flies, is promoted to associate professor

Neuroscientist Gaby Maimon, who heads the Laboratory of Integrative Brain Function, will become an associate professor as of January 1, 2017. His research program explores how the brain performs calculations to estimate values like angles and time, and is based on the idea that fruit flies, his r...

Awards, Arrivals, and Promotions

Congratulations to our latest award winners: Winrich Freiwald has won the 2016 W. Alden Spencer Award. The prize, given by Columbia University, recognizes outstanding contributions in neuroscience. Dr. Freiwald, who shares the prize with his long-time collaborator Doris Y. Tsao of Caltech, presen...

Pioneering drug discovery company Bridge Medicines launched to advance promising early technologies in major academic institutions through human proof of concept

The Tri-Institutional Therapeutics Discovery Institute, a partnership between Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine and Takeda, joins with Deerfield Management and Bay City Capital to create an accelerated path to innovative therapies to treat ...